The DOI matches its Crossref record; 245 of the 245 references it cites were found in a registry or an index.
Cell death pathways in Parkinson’s disease: proximal triggers, distal effectors, and final steps
Open accessAbstract
Parkinson’s disease (PD) is a common neurodegenerative disorder. Neuronal cell death in PD is still poorly understood, despite a wealth of potential pathogenic mechanisms and pathways. Defects in several cellular systems have been implicated as early triggers that start cells down the road toward neuronal death. These include abnormal protein accumulation, particularly of alpha-synuclein; altered protein degradation via multiple pathways; mitochondrial dysfunction; oxidative stress; neuroinflammation; and dysregulated kinase signaling. As dysfunction in these systems mounts, pathways that are more explicitly involved in cell death become recruited. These include JNK signaling, p53 activation, cell cycle re-activation, and signaling through bcl-2 family proteins. Eventually, neurons become overwhelmed and degenerate; however, even the mechanism of final cell death in PD is still unsettled. In this review, we will discuss cell death triggers and effectors that are relevant to PD, highlighting important unresolved issues and implications for the development of neuroprotective therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–245 of 245
Mitochondrial function in Parkinson's disease
Schapira, A. H. V., Mann, V. M., Cooper, J. A. D., Krige, D., Jenner, P. G., & MARSDEN, C. D. (1992) · Annals of Neurology · doi:10.1002/ana.410320720 · Cited by 109
Analysis of gene expression changes in a cellular model of Parkinson disease
Ryu, E. J., Angelastro, J. M., & Greene, L. A. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.08.016 · Cited by 105
Self-citationp25/Cdk5-mediated retinoblastoma phosphorylation is an early event in neuronal cell death
Hamdane, M., Bretteville, A., Sambo, A., Schindowski, K., Bégard, S., Delacourte, A., Bertrand, P., & Buée, L. (2005) · Journal of Cell Science · doi:10.1242/jcs.01724 · Cited by 105
A novel in vivo post‐translational modification of p53 by PARP‐1 in MPTP‐induced parkinsonism
Mandir, A. S., Simbulan-Rosenthal, C. M., Poitras, M. F., Lumpkin, J. R., Dawson, V. L., Smulson, M. E., & Dawson, T. M. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01144.x · Cited by 102
Nair, V. D., McNaught, K. S. P., González‐Maeso, J., Sealfon, S. C., & Olanow, C. W. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603950200 · Cited by 102
von Coelln, R., Thomas, B., Andrabi, S. A., Lim, K., Savitt, J. M., Saffary, R., Stirling, W. L. H., Bruno, K. J., Hess, E. J., Lee, M. K., et al. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.0414-06.2006 · Cited by 101
Exacerbated synucleinopathy in mice expressing A53T SNCA on a Snca null background
Cabin, D. E., Gispert-Sánchez, S., Murphy, D., Auburger, G. W. J., Myers, R. R., & Nussbaum, R. L. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.02.026 · Cited by 98
Design of an N-Methylated Peptide Inhibitor of α-Synuclein Aggregation Guided by Solid-State NMR
Madine, J., Doig, A. J., & Middleton, D. A. (2008) · Journal of the American Chemical Society · doi:10.1021/ja075356q · Cited by 96
Cell death and apoptosis regulating proteins in Parkinson's disease - a cautionary note
Wüllner, U., Kornhuber, J., Weller, M., Schulz, J. B., Löschmann, P.-A., Riederer, P. F., & Klockgether, T. (1999) · Acta Neuropathologica · doi:10.1007/s004010051005 · Cited by 96
Activation of p53 signaling initiates apoptotic death in a cellular model of Parkinson’s disease
Nair, V. D. (2006) · APOPTOSIS · doi:10.1007/s10495-006-6316-3 · Cited by 88
BimEL up‐regulation potentiates AIF translocation and cell death in response to MPTP
Liou, A. K. F., Zhou, Z., Pei, W., Lim, T., Yin, X., & Chen, J. (2005) · The FASEB Journal · doi:10.1096/fj.04-3258fje · Cited by 88
Rideout, H. J., Lang‐Rollin, I., Savalle, M., & Stefanis, L. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03124.x · Cited by 86
Phthalocyanine Tetrasulfonates Affect the Amyloid Formation and Cytotoxicity of α-Synuclein
Lee, E.-N., Cho, H.-J., Lee, C.-H., Lee, D., Chung, K. C., & Paik, S. R. (2004) · Biochemistry · doi:10.1021/bi0356707 · Cited by 86
Microtubule: A Common Target for Parkin and Parkinson’s Disease Toxins
Feng, J. (2006) · The Neuroscientist · doi:10.1177/1073858406293853 · Cited by 84
WldS mice are protected against the Parkinsonian mimetic MPTP
HASBANI, D., & O’Malley, K. L. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2006.05.017 · Cited by 83
Chu, C. T., Zhu, J., Cao, G., Signore, A. P., Wang, S., & Chen, J. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03329.x · Cited by 83
Absence of dopaminergic neuronal degeneration and oxidative damage in aged DJ-1-deficient mice
Yamaguchi, H., & Shen, J. (2007) · Molecular Neurodegeneration · doi:10.1186/1750-1326-2-10 · Cited by 83
p35 nck5a and cyclin-dependent kinase 5 colocalize in Lewy bodies of brains with Parkinson's disease
Nakamura, S., Kawamoto, Y., Nakano, S., Akiguchi, I., & Kimura, J. (1997) · Acta Neuropathologica · doi:10.1007/s004010050687 · Cited by 82
Puma and p53 Play Required Roles in Death Evoked in a Cellular Model of Parkinson Disease
Biswas, S. C., Ryu, E. J., Park, C., Malagelada, C., & Greene, L. A. (2005) · Neurochemical Research · doi:10.1007/s11064-005-6877-5 · Cited by 80
Self-citationThomas, B., von Coelln, R., Mandir, A. S., Trinkaus, D. B., Farah, M. H., Lim, K., Calingasan, N. Y., Beal, M. F., Dawson, V. L., & Dawson, T. M. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.12.021 · Cited by 76
Activation of the calpain/cdk5/p25 pathway in the girus cinguli in Parkinson's disease
Alvira, D., Ferrer, I., Cuesta, J., García‐Castro, B., Pallàs, M., & Camins, A. (2007) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2007.09.005 · Cited by 71
Rodríguez‐Blanco, J., Martín, V., Herrera, F., García‐Santos, G., Antolín, I., & Rodríguez, C. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05588.x · Cited by 70
Parkinson’s Disease and Related Synucleinopathies are a New Class of Nervous System Amyloidoses
Trojanowski, J. Q., & Lee, V. M. ‐. (2002) · NeuroToxicology · doi:10.1016/s0161-813x(02)00065-7 · Cited by 66
Proteasome activation as a novel antiaging strategy
Chondrogianni, N., & Gonos, E. S. (2008) · IUBMB Life · doi:10.1002/iub.99 · Cited by 63
Fabre, E., Monserrat, J., Herrero, A., Barja, G., & Leret, M. L. (1999) · Journal of Physiology and Biochemistry · doi:10.1007/bf03655585 · Cited by 60
Rideout, H. J., Dietrich, P., Wang, Q., Dauer, W. T., & Stefanis, L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405146200 · Cited by 59
Wang, H., Imai, Y., Inoue, H., Kataoka, A., Iita, S., Nukina, N., & Takahashi, R. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05607.x · Cited by 58
Lang‐Rollin, I., Vekrellis, K., Wang, Q., Rideout, H. J., & Stefanis, L. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02684.x · Cited by 58
O’Malley, K. L. (2003) · Neurobiology of Disease · doi:10.1016/s0969-9961(03)00013-5 · Cited by 57
Parkin and Endoplasmic Reticulum Stress
Takahashi, R., Imai, Y., Hattori, N., & Mizuno, Y. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb07467.x · Cited by 55
Zheng, X. S., Chu, F., Mirkin, B. L., Sudha, T., Mousa, S. A., & Rebbaa, A. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.07.027 · Cited by 55
Alvira, D., Tajes, M., Verdaguer, E., de Arriba, S. G., Allgaier, C., Matute, C., Trullás, R., Jiménez, A., Pallàs, M., & Camins, A. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.01.042 · Cited by 50
Menéndez, J., Rodríguez‐Navarro, J. A., Solano, R. M., Casarejos, M. J., Rodal, I., Guerrero, R., Sánchez, M. P., Ávila, J., Mena, M. A., & de Yébenes, J. G. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl129 · Cited by 49
Du, Y., Li, X., Yang, D., Zhang, X., Chen, S., Huang, K., & Le, W. (2008) · Experimental Biology and Medicine · doi:10.3181/0712-rm-329 · Cited by 47
CDKs: taking on a role as mediators of dopaminergic loss in Parkinson's disease
Smith, P. D., O'Hare, M. J., & Park, D. S. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.07.003 · Cited by 45
Hattori, N., Shimura, H., Kubo, S., Kitada, T., Wang, M., Asakawa, S., Minashima, S., Shimizu, N., Suzuki, T., Tanaka, K., et al. (2000) · Neuropathology · doi:10.1046/j.1440-1789.2000.00312.x · Cited by 41
Wilhelm, M., Xu, Z., Kukekov, N. V., Gire, S., & Greene, L. A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m607038200 · Cited by 40
Self-citationMolecular biology changes associated with LRRK2 mutations in Parkinson's disease
Lu, Y. W., & Tan, E. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21656 · Cited by 39
p53-mediated mitochondrial dysfunction by proteasome inhibition in dopaminergic SH-SY5Y cells
Nakaso, K., 吉本, 祐., Yano, H., Takeshima, T., & Nakashima, K. (2003) · Neuroscience Letters · doi:10.1016/j.neulet.2003.10.048 · Cited by 37
Ahn, T., & Jeon, B. S. (2006) · Brain Research · doi:10.1016/j.brainres.2006.02.097 · Cited by 36
Hasbani, D. M., Perez, F. A., Palmiter, R. D., & O’Malley, K. L. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.0130-05.2005 · Cited by 36
Cell Type-Specific Upregulation of Parkin in Response to ER Stress
Wang, H., Imai, Y., Kataoka, A., & Takahashi, R. (2007) · Antioxidants and Redox Signaling · doi:10.1089/ars.2006.1522 · Cited by 33
BAX protein-immunoreactivity in midbrain neurons of Parkinson’s disease patients
Horowitz, J. M., Pastor, D. M., Goyal, A., Kar, S., Ramdeen, N., Hallas, B. H., & Torres, G. (2003) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2003.08.005 · Cited by 31
Lack of α‐synuclein does not alter apoptosis of neonatal catecholaminergic neurons
Stefanis, L., Wang, Q., Oo, T. F., Lang‐Rollin, I., Burke, R. E., & Dauer, W. T. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03638.x · Cited by 29
Current concepts on the etiology and pathogenesis of Parkinson disease
Fahn, S., Jankovic, J. J., & Hallett, M. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-2369-4.00005-6 · Cited by 7
Cited by
Pathological roles of MAPK signaling pathways in human diseases
Kim, E. K., & Choi, E.-J. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.12.009 · Cited by 2,472
Role of Bcl-2 family proteins and caspases in the regulation of apoptosis
Ola, M. S., Nawaz, M., & Ahsan, H. (2011) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-010-0709-x · Cited by 920
Oxidative stress in the aging substantia nigra and the etiology of Parkinson's disease
Trist, B. G., Hare, D. J., & Double, K. L. (2019) · Aging Cell · doi:10.1111/acel.13031 · Cited by 778
Basic mechanisms of neurodegeneration: a critical update
Jellinger, K. A. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01010.x · Cited by 596
Caspase‐3: Structure, function, and biotechnological aspects
Asadi, M., Taghizadeh, S., Kaviani, E., Vakili, O., Taheri‐Anganeh, M., Tahamtan, M., & Savardashtaki, A. (2022) · Biotechnology and Applied Biochemistry · doi:10.1002/bab.2233 · Cited by 530
Metadata
- Authors
- Levy, O. A., Malagelada, C., & Greene, L. A.
- Venue
- Apoptosis
- Published
- 2009-01-23
- Volume
- 14
- Issue
- 4
- Pages
- 478-500
- ISSN
- 1360-8185 (ISSN-L)
- 1573-675X
- OpenAlex
- W2055874717
- Cited by
- 287
- References
- 245
- FWCI
- 16.50
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.